Novel KCNQ1 mutations in patients after myocardial infarction

Cardiology Journal

Volumn 15, Issue 3, 2008, Pages 252-260

  Olszak Waśkiewicz, Marlena ^a   Dziuk, Mirosław ^a   Kubik, Leszek ^a   Kaczanowski, Radosław ^b   Kucharczyk, Krzysztof ^b  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

^b Kucharczyk Techniki Elektroforetyczne Sp z oo   (Poland)

Author keywords

Arrhythmias; Mutation; Myocardial infarction

Indexed keywords

POTASSIUM CHANNEL KCNQ1; KCNQ1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE COURSE; EXON; FEMALE; GENE MUTATION; GENETIC SCREENING; HEART ARREST; HEART INFARCTION; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HOLTER MONITORING; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; QT DISPERSION; QT INTERVAL; GENETICS; HEART ARRHYTHMIA; MUTATION; SUDDEN DEATH;

AGED; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; KCNQ1 POTASSIUM CHANNEL; MALE; MUTATION; MYOCARDIAL INFARCTION;

EID: 54049137723     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Wang Q, Curran ME, Splawski I et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet, 1996; 12: 17-23.
2. Donger C, Denjoy I, Berthet M et al. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation, 1997; 96: 2778-2781.
3. Larsen LA, Andersen PS, Kanters JK, Jacobsen JR, Vuust J, Christiansen M. A single strand conformation polymorphism//heteroduplex (SSCP/HD) method for detection of mutations in 15 exons of the KVLQT1 gene, associated with long QT syndrome. Clin Chim Acta, 1999; 280: 113-125.
4. Li H, Chen Q, Moss AJ et al. New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. Circulation, 1998; 97: 1264-1269.
5. Neyroud N, Richard P, Vignier N et al. Genomic organization of the KCNQ1 K+ channel gene and identification of C-terminal mutations in the long-QT syndrome. Circ Res, 1999; 84: 290-297.
6. Priori SG, Aliot E, Blomstrom-Lundqvist C et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J, 2001; 22: 1374-1450.
7. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT. Mutations in the hminK gene cause long QT syndrome and suppress Iks function. Nat Genet, 1997; 17: 338-340.
8. Wang Q, Li Z, Shen J, Keating MT. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics, 1996; 34: 9-16.
9. Kaczanowski R, Trzeciak L, Kucharczyk K. Multitemperature single-strand conformation polymorphism. Electrophoresis, 2001; 22: 3539-3545.
10. Viskin S, Justo D, Halkin A, Zeltser D. Long QT syndrome caused by non-cardiac drugs. Prog Cardiovasc Dis, 2003; 45: 415-427.
11. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med, 2004; 350: 1013-1022.
12. Kubota T, Shimizu W, Kamakura S, Horie M. Hypokalemia--induced long QT syndrome with an underlying novel missense mutation in S4-S5 linker of KCNQ1. J Cardiovasc Electrophysiol, 2000; 11: 1048-1054.
13. Napolitano C, Schwarz PJ, Brown AM et al. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J Cardiovasc Electrophysiol, 2000; 11: 691-696.
14. Ahnve S, Gilpin E, Madsen EB, Froelicher V, Henning H, Ross J. Prognostic importance of QTc interval at discharge after acute myocardial infarction: A multicenter study of 865 patients. Am Heart J, 1984; 108: 395-400.
15. Spargias KS, Lindsay SJ, Kawar GI et al. QT dispersion as a predictor of long-term mortality in patients with acute myocardial infarction and clinical evidence of heart failure. Eur Heart J, 1999; 20: 1158-1165.
16. Koo SH, Teo WS, Ching ChK, Chan SH, Lee E JD. Mutation screening in KCNQ1, HERG, KCNE1, KCNE2 and SCN5A genes in a long QT syndrome family. Ann Acad Med, 2007; 36: 394-398.
17. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long QT syndrome. Clinical impact. Circulation, 1999; 99: 529-533.
18. Derebecka N, Holysz M, Dankowski R, Wierzchowiecki M, Trzeciak WH. Polymorphism in intron 23 of the endothelial nitric oxide synthase gene (NOS3) is not associated with hypertension. Acta Biochim Pol, 2002; 49: 263-268.
19. Ignacak M, Niedziela M, Trzeciak WH. Transition C2718T in the AR gene, resulting in generation of a termination codon and truncated form of the androgen receptor, causes complete androgen insensitivity syndrome. J Appl Genet, 2002; 43: 109-114.
20. Bezak A, Kaczanowski R, Dossenbach-Glaninger A, Kucharczyk K, Lubitz W, Hopmeier P. Detection of single nucleotide polymorphismus in coagulation factor XI deficient patients by multitemperature single-strand conformation Polymorphism analysis. J Clin Labor Analysis, 2005; 19: 233-240.
21. Zhang L, Vincent M, Baralle M et al. An intronic mutation causes long QT syndrome. J Am Coll Cardiol, 2004; 44: 1283-1291.
22. Romano M, Danek GM, Baralle FE, Mazzotti R, Filocamo M. Functional characterization of the novel mutation IVS8 (-11delC) (-14T>A) in the intron 8 of the glucocerebrosidase gene of two Italian siblings with Gaucher disease type I. Blood Cells Mol Dis, 2000; 26: 171-176.
23. Baralle D, Baralle M. Splicing in action: assessing disease causing sequence changes. J Med Genet, 2005; 42: 737-748.
24. Buratti E, Barelle M, Barelle FE. Defective splicing, disease and therapy: searching for master checkpoints in exon definition. Nucleic Acids Res, 2006; 34: 3494-3510.
25. Faustyno NA, Cooper TA. Pre-mRNA splicing and human disease. Genes Dev, 2003; 17: 419-437.
26. Mayer K, Ballhausen W, Leistner W, Rott H. Three novel types of splicing aberrations in the tuberous sclerosis TSC2 gene caused by mutations apart from splice consensus sequence. Biochim Biophys Acta, 2000; 1502: 495-507.
27. Seti F, Abbott GW, Wei J et al. A common polymorphism associated with antibiotic-induced cardiac arrhthmia. Proc Natl Acad Sci USA, 2000; 97: 10613-10618.
28. Yang P, Kanki H, Drolet B et al. Alleli variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation, 2002; 105: 1943-1948.
29. The CAST Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med, 1989; 321: 406-412.